These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 29338983)
1. Dipyridamole plus Triflusal versus Triflusal Alone in Infarct Reduction after Middle Cerebral Artery Occlusion. Amtul Z; Haque W; Cechetto DF J Stroke Cerebrovasc Dis; 2018 May; 27(5):1283-1287. PubMed ID: 29338983 [TBL] [Abstract][Full Text] [Related]
2. Effects of triflusal and aspirin in a rat model of cerebral ischemia. Whitehead SN; Bayona NA; Cheng G; Allen GV; Hachinski VC; Cechetto DF Stroke; 2007 Feb; 38(2):381-7. PubMed ID: 17194886 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of triflusal and its main metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid (HTB), in the postischemic brain. Kim SW; Choi KJ; Park JY; Yoon SH; Lee JK Neurosci Lett; 2017 Mar; 643():59-64. PubMed ID: 28189746 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats. Tan F; Li H; Ma M; Yu Y Brain Res; 2014 Apr; 1560():83-90. PubMed ID: 24602692 [TBL] [Abstract][Full Text] [Related]
6. Effects of acute post-treatment with dipyridamole in a rat model of focal cerebral ischemia. García-Bonilla L; Sosti V; Campos M; Penalba A; Boada C; Sumalla M; Hernández-Guillamon M; Rosell A; Montaner J Brain Res; 2011 Feb; 1373():211-20. PubMed ID: 21146508 [TBL] [Abstract][Full Text] [Related]
7. Emulsified Isoflurane Protects Against Transient Focal Cerebral Ischemia Injury in Rats via the PI3K/Akt Signaling Pathway. Zhang H; Xiong X; Liu J; Gu L; Li F; Wan Y; Xu S Anesth Analg; 2016 May; 122(5):1377-84. PubMed ID: 26859875 [TBL] [Abstract][Full Text] [Related]
8. The Synergistic Neuroprotective Effects of Combined Rosuvastatin and Resveratrol Pretreatment against Cerebral Ischemia/Reperfusion Injury. Liu Y; Yang H; Jia G; Li L; Chen H; Bi J; Wang C J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1697-1704. PubMed ID: 29525080 [TBL] [Abstract][Full Text] [Related]
9. Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat. Kuhmonen J; Haapalinna A; Sivenius J J Neural Transm (Vienna); 2001; 108(3):261-71. PubMed ID: 11341477 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion. Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327 [TBL] [Abstract][Full Text] [Related]
12. Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model. Milani D; Clark VW; Cross JL; Anderton RS; Knuckey NW; Meloni BP BMC Neurosci; 2016 May; 17(1):19. PubMed ID: 27142074 [TBL] [Abstract][Full Text] [Related]
13. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Yang C; Zhang X; Fan H; Liu Y Brain Res; 2009 Jul; 1282():133-41. PubMed ID: 19445907 [TBL] [Abstract][Full Text] [Related]
14. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats. Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950 [TBL] [Abstract][Full Text] [Related]
15. Combination of Zizyphus jujuba and silymarin showed better neuroprotective effect as compared to single agent in MCAo-induced focal cerebral ischemia in rats. Gupta S; Gupta YK J Ethnopharmacol; 2017 Feb; 197():118-127. PubMed ID: 27452658 [TBL] [Abstract][Full Text] [Related]
16. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361 [TBL] [Abstract][Full Text] [Related]
17. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of nobiletin on cerebral ischemia-reperfusion injury in transient middle cerebral artery-occluded rats. Yasuda N; Ishii T; Oyama D; Fukuta T; Agato Y; Sato A; Shimizu K; Asai T; Asakawa T; Kan T; Yamada S; Ohizumi Y; Oku N Brain Res; 2014 Apr; 1559():46-54. PubMed ID: 24534366 [TBL] [Abstract][Full Text] [Related]